Group One Trading
FULC icon

Group One Trading’s Fulcrum Therapeutics FULC Stock Holding History

Group One Trading’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154K Buy
42,000
+37,700
+877% +$229K ﹤0.01% 4507
2026
Q1 		$33K Sell
4,300
-1,000
-19% -$9.28K ﹤0.01% 5588
2025
Q4 		$59.9K Buy
5,300
+5,200
+5,200% +$52.9K ﹤0.01% 5445
2025
Q3 		$920 Hold
100
– – ﹤0.01% 8068
2025
Q2 		$688 Hold
100
– – ﹤0.01% 7621
2025
Q1 		$288 Sell
100
-4,000
-98% -$14.7K ﹤0.01% 7345
2024
Q4 		$19.3K Sell
4,100
-62,700
-94% -$231K ﹤0.01% 5710
2024
Q3 		$238K Buy
+66,800
New +$496K ﹤0.01% 3459
2024
Q1 		– Sell
-50,000
Closed -$338K – 7337
2023
Q4 		$338K Buy
50,000
+43,500
+669% +$193K ﹤0.01% 3400
2023
Q3 		$28.9K Buy
6,500
+5,400
+491% +$23.6K ﹤0.01% 5580
2023
Q2 		$3.63K Buy
+1,100
New +$3.23K ﹤0.01% 6853
2023
Q1 		– Sell
-2,500
Closed -$18.2K – 7445
2022
Q4 		$18.2K Buy
2,500
+2,400
+2,400% +$15.7K ﹤0.01% 5655
2022
Q3 		$1K Sell
100
-300
-75% -$2.15K ﹤0.01% 7308
2022
Q2 		$2K Sell
400
-5,700
-93% -$55.7K ﹤0.01% 7399
2022
Q1 		$144K Buy
6,100
+5,800
+1,933% +$82.1K ﹤0.01% 5132
2021
Q4 		$5K Sell
300
-11,000
-97% -$218K ﹤0.01% 7630
2021
Q3 		$319K Buy
+11,300
New +$214K ﹤0.01% 4678

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's FULC Position: Q2 2026 in Review

Group One Trading reduced its Fulcrum Therapeutics (FULC) stake by 93% in Q2 2026, selling an estimated $305K and leaving 3,556 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #6250.

Group One Trading first reported a position in FULC in Q3 2021 and has held it in 15 quarters since. The position peaked at $412K in Q1 2026. 154 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Group One Trading held 3,556 shares of Fulcrum Therapeutics worth $13K as of Q2 2026.
  • Group One Trading sold 50,200 Fulcrum Therapeutics shares in Q2 2026, an estimated $305K.
  • Fulcrum Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6250 holding.
  • Group One Trading first reported a position in Fulcrum Therapeutics in Q3 2021 and has held it in 15 quarters since.
  • Group One Trading's Fulcrum Therapeutics position peaked at $412K in Q1 2026.
  • 154 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.